139 related articles for article (PubMed ID: 22415333)
1. Famotidine in the treatment of functional dyspepsia: a randomized double-blind, placebo-controlled trial.
Amini M; Ghamar Chehreh ME; Khedmat H; Valizadegan G; Babaei M; Darvishi A; Taheri S
J Egypt Public Health Assoc; 2012 Apr; 87(1-2):29-33. PubMed ID: 22415333
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsia.
Kato M; Watanabe M; Konishi S; Kudo M; Konno J; Meguro T; Kitamori S; Nakagawa S; Shimizu Y; Takeda H; Asaka M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():27-31. PubMed ID: 15943843
[TBL] [Abstract][Full Text] [Related]
3. A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia.
Hojo M; Nagahara A; Asaoka D; Takeda T; Izumi K; Matsumoto K; Ueyama H; Shimada Y; Matsumoto K; Nojiri S; Watanabe S
Digestion; 2017; 96(1):5-12. PubMed ID: 28605740
[TBL] [Abstract][Full Text] [Related]
4. Effect of Chaihu-Shugan-San on functional dyspepsia and gut microbiota: A randomized, double-blind, placebo-controlled trial.
Wang Y; Jia Y; Liu X; Yang K; Lin Y; Shao Q; Ling J
J Ethnopharmacol; 2024 Mar; 322():117659. PubMed ID: 38151181
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study.
Kinoshita Y; Chiba T;
J Gastroenterol; 2012 Apr; 47(4):377-86. PubMed ID: 22183857
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessment.
See MC; Birnbaum AH; Schechter CB; Goldenberg MM; Benkov KJ
Dig Dis Sci; 2001 May; 46(5):985-92. PubMed ID: 11341669
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Mentha pulegium extract in the treatment of functional dyspepsia: A randomized double-blind placebo-controlled clinical trial.
Khonche A; Fallah Huseini H; Abdi H; Mohtashami R; Nabati F; Kianbakht S
J Ethnopharmacol; 2017 Jul; 206():267-273. PubMed ID: 28571727
[TBL] [Abstract][Full Text] [Related]
8. Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study.
Tan VP; Cheung TK; Wong WM; Pang R; Wong BC
World J Gastroenterol; 2012 Nov; 18(42):6127-33. PubMed ID: 23155342
[TBL] [Abstract][Full Text] [Related]
9. Rikkunshito simultaneously improves dyspepsia correlated with anxiety in patients with functional dyspepsia: A randomized clinical trial (the DREAM study).
Tominaga K; Sakata Y; Kusunoki H; Odaka T; Sakurai K; Kawamura O; Nagahara A; Takeuchi T; Fujikawa Y; Oshima T; Kato M; Furuta T; Murakami K; Chiba T; Miwa H; Kinoshita Y; Higuchi K; Kusano M; Iwakiri R; Fujimoto K; Tack JF; Arakawa T
Neurogastroenterol Motil; 2018 Jul; 30(7):e13319. PubMed ID: 29498457
[TBL] [Abstract][Full Text] [Related]
10. Zhizhu Kuanzhong Capsule in treating patients with functional dyspepsia postprandial distress syndrome: study protocol for a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial.
Xiao M; Zhong LLD; Lam WC; Zhao Y; Gwee KA; Holtmann G; Tack J; Suzuki H; Chen MH; Xiao Y; Hou X; Liu J; Li Y; Tang XD; Lu F
Trials; 2022 Jun; 23(1):454. PubMed ID: 35655286
[TBL] [Abstract][Full Text] [Related]
11. A traditional herbal formula, Hyangsa-Pyeongwi san (HPS), improves quality of life (QoL) of the patient with functional dyspepsia (FD): randomized double-blinded controlled trial.
Kim JB; Shin JW; Kang JY; Son CG; Kang W; Lee HW; Lee DS; Park YC; Cho JH
J Ethnopharmacol; 2014; 151(1):279-86. PubMed ID: 24239600
[TBL] [Abstract][Full Text] [Related]
12. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials.
Talley NJ; Tack J; Ptak T; Gupta R; Giguère M
Gut; 2008 Jun; 57(6):740-6. PubMed ID: 17965059
[TBL] [Abstract][Full Text] [Related]
13. Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled "ENTER" trial.
van Zanten SV; Armstrong D; Chiba N; Flook N; White RJ; Chakraborty B; Gasco A
Am J Gastroenterol; 2006 Sep; 101(9):2096-106. PubMed ID: 16817845
[TBL] [Abstract][Full Text] [Related]
14. On-demand treatment of acute heartburn with the antacid hydrotalcite compared with famotidine and placebo: randomized double-blind cross-over study.
Holtmeier W; Holtmann G; Caspary WF; Weingärtner U
J Clin Gastroenterol; 2007 Jul; 41(6):564-70. PubMed ID: 17577112
[TBL] [Abstract][Full Text] [Related]
15. Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia.
Tan VP; Liu KS; Lam FY; Hung IF; Yuen MF; Leung WK
Aliment Pharmacol Ther; 2017 Mar; 45(6):767-776. PubMed ID: 28112426
[TBL] [Abstract][Full Text] [Related]
16. Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia.
Kinoshita Y; Hashimoto T; Kawamura A; Yuki M; Amano K; Sato H; Adachi K; Sato S; Oshima N; Takashima T; Kitajima N; Abe K; Suetsugu H
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():37-41. PubMed ID: 15943845
[TBL] [Abstract][Full Text] [Related]
17. Curcuma longa Linn versus omeprazole in treatment of functional dyspepsia: A randomized, double-blind, placebo-controlled trial.
Yongwatana K; Harinwan K; Chirapongsathorn S; Opuchar K; Sanpajit T; Piyanirun W; Puttapitakpong C
J Gastroenterol Hepatol; 2022 Feb; 37(2):335-341. PubMed ID: 34652861
[TBL] [Abstract][Full Text] [Related]
18. New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline.
Otaka M; Jin M; Odashima M; Matsuhashi T; Wada I; Horikawa Y; Komatsu K; Ohba R; Oyake J; Hatakeyama N; Watanabe S
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():42-6. PubMed ID: 15943846
[TBL] [Abstract][Full Text] [Related]
19. A Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Comparative Clinical Study to Evaluate the Efficacy and Safety of OLNP-06
Panda MPharm SK; Nirvanashetty PhD S; Parachur BTech VA; Krishnamoorthy MPharm C; Dey MSc S
J Diet Suppl; 2022; 19(2):226-237. PubMed ID: 33305631
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of jollab to treat functional dyspepsia: a randomized placebo-controlled clinical trial.
Pasalar M; Choopani R; Mosaddegh M; Kamalinejad M; Mohagheghzadeh A; Fattahi MR; Ghanizadeh A; Bagheri Lankarani K
Explore (NY); 2015; 11(3):199-207. PubMed ID: 25777290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
